NeuroMetrix, Inc.
NURO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,033 | $5,901 | $8,256 | $8,253 |
| % Growth | -48.6% | -28.5% | 0% | – |
| Cost of Goods Sold | $1,353 | $1,954 | $2,506 | $2,332 |
| Gross Profit | $1,680 | $3,947 | $5,750 | $5,922 |
| % Margin | 55.4% | 66.9% | 69.6% | 71.7% |
| R&D Expenses | $1,793 | $2,778 | $3,240 | $2,596 |
| G&A Expenses | $6,331 | $4,956 | $4,387 | $3,990 |
| SG&A Expenses | $8,669 | $8,321 | $7,252 | $5,610 |
| Sales & Mktg Exp. | $2,338 | $3,365 | $2,866 | $1,620 |
| Other Operating Expenses | $0 | $0 | $0 | $3 |
| Operating Expenses | $10,462 | $11,099 | $10,492 | $8,206 |
| Operating Income | -$8,782 | -$7,152 | -$4,742 | -$2,285 |
| % Margin | -289.6% | -121.2% | -57.4% | -27.7% |
| Other Income/Exp. Net | $976 | $622 | $325 | $3 |
| Pre-Tax Income | -$7,806 | -$6,529 | -$4,417 | -$2,282 |
| Tax Expense | $0 | $0 | $0 | -$76 |
| Net Income | -$7,806 | -$6,529 | -$4,367 | -$2,205 |
| % Margin | -257.4% | -110.6% | -52.9% | -26.7% |
| EPS | -3.96 | -6.27 | -4.9 | -0.86 |
| % Growth | 36.8% | -28% | -469.8% | – |
| EPS Diluted | -3.96 | -6.27 | -4.9 | -0.86 |
| Weighted Avg Shares Out | 1,970 | 1,041 | 891 | 2,565 |
| Weighted Avg Shares Out Dil | 1,970 | 1,042 | 891 | 2,565 |
| Supplemental Information | – | – | – | – |
| Interest Income | $47 | $257 | $325 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $56 | $49 | $76 |
| EBITDA | -$8,782 | -$7,096 | -$4,692 | -$2,208 |
| % Margin | -289.6% | -120.2% | -56.8% | -26.8% |